WD Rutherford’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Sell |
3,310
-1,475
| -31% | -$115K | 0.12% | 66 |
|
|
2025
Q1 | $339K | Sell |
4,785
-4,697
| -50% | -$332K | 0.18% | 67 |
|
|
2024
Q4 | $702K | Sell |
9,482
-8,893
| -48% | -$658K | 0.33% | 58 |
|
|
2024
Q3 | $1.21M | Sell |
18,375
-22,745
| -55% | -$1.5M | 0.59% | 52 |
|
|
2024
Q2 | $3.8M | Buy |
41,120
+420
| +1% | +$38.8K | 1.91% | 18 |
|
|
2024
Q1 | $3.89M | Buy |
40,700
+1,030
| +3% | +$98.4K | 2.01% | 20 |
|
|
2023
Q4 | $2.98M | Sell |
39,670
-395
| -1% | -$29.7K | 1.73% | 29 |
|
|
2023
Q3 | $2.78M | Sell |
40,065
-3,700
| -8% | -$256K | 1.9% | 23 |
|
|
2023
Q2 | $4.13M | Sell |
43,765
-170
| -0.4% | -$16K | 2.64% | 9 |
|
|
2023
Q1 | $3.63M | Sell |
43,935
-115
| -0.3% | -$9.51K | 2.56% | 15 |
|
|
2022
Q4 | $3.31M | Sell |
44,050
-935
| -2% | -$70.2K | 2.6% | 12 |
|
|
2022
Q3 | $3.72M | Sell |
44,985
-1,315
| -3% | -$109K | 2.98% | 6 |
|
|
2022
Q2 | $4.4M | Sell |
46,300
-20
| -0% | -$1.9K | 3.4% | 6 |
|
|
2022
Q1 | $5.45M | Sell |
46,320
-115
| -0.2% | -$13.5K | 3.12% | 6 |
|
|
2021
Q4 | $6.02M | Sell |
46,435
-740
| -2% | -$95.9K | 3.05% | 6 |
|
|
2021
Q3 | $5.34M | Sell |
47,175
-130
| -0.3% | -$14.7K | 2.9% | 6 |
|
|
2021
Q2 | $4.9M | Buy |
47,305
+130
| +0.3% | +$13.5K | 2.73% | 8 |
|
|
2021
Q1 | $3.95M | Sell |
47,175
-665
| -1% | -$55.6K | 2.45% | 15 |
|
|
2020
Q4 | $4.36M | Buy |
+47,840
| New | +$4.36M | 2.76% | 14 |
|